Cardinal Capital Management Cuts Position in Dentsply International Inc. (XRAY)
Cardinal Capital Management cut its position in Dentsply International Inc. (NASDAQ:XRAY) by 0.5% during the second quarter, Holdings Channel reports. The institutional investor owned 67,070 shares of the company’s stock after selling 328 shares during the period. Dentsply International makes up 1.7% of Cardinal Capital Management’s portfolio, making the stock its 19th largest position. Cardinal Capital Management’s holdings in Dentsply International were worth $4,161,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Glenmede Trust Co. NA boosted its position in Dentsply International by 92.5% in the first quarter. Glenmede Trust Co. NA now owns 6,918 shares of the company’s stock worth $425,000 after buying an additional 3,325 shares in the last quarter. Aperio Group LLC boosted its position in Dentsply International by 115.7% in the first quarter. Aperio Group LLC now owns 106,750 shares of the company’s stock worth $6,579,000 after buying an additional 57,270 shares in the last quarter. Nisa Investment Advisors L.L.C. boosted its position in Dentsply International by 105.8% in the first quarter. Nisa Investment Advisors L.L.C. now owns 44,942 shares of the company’s stock worth $2,770,000 after buying an additional 23,101 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. bought a new position in Dentsply International during the first quarter worth about $1,242,000. Finally, Ngam Advisors L.P. boosted its position in Dentsply International by 357.1% in the first quarter. Ngam Advisors L.P. now owns 87,622 shares of the company’s stock worth $5,400,000 after buying an additional 68,453 shares in the last quarter. 94.58% of the stock is owned by institutional investors and hedge funds.
Dentsply International Inc. (NASDAQ:XRAY) traded down 0.66% during mid-day trading on Monday, reaching $59.04. 1,681,803 shares of the company traded hands. Dentsply International Inc. has a 52 week low of $51.28 and a 52 week high of $65.83. The stock’s 50 day moving average price is $60.27 and its 200 day moving average price is $61.45.
Dentsply International (NASDAQ:XRAY) last issued its earnings results on Friday, August 5th. The company reported $0.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.70 by $0.06. Dentsply International had a net margin of 11.99% and a return on equity of 9.18%. The business earned $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter in the prior year, the business posted $0.73 EPS. The company’s revenue for the quarter was up 46.4% on a year-over-year basis. Equities research analysts predict that Dentsply International Inc. will post $2.76 EPS for the current fiscal year.
The business also recently announced a dividend, which will be paid on Friday, October 14th. Stockholders of record on Friday, September 30th will be issued a $0.0775 dividend. The ex-dividend date of this dividend is Wednesday, September 28th. Dentsply International’s payout ratio is 14.49%.
A number of research analysts have issued reports on XRAY shares. Credit Suisse Group AG reaffirmed a “buy” rating on shares of Dentsply International in a report on Sunday, June 5th. Piper Jaffray Cos. started coverage on shares of Dentsply International in a report on Monday, June 13th. They set an “overweight” rating and a $70.00 target price for the company. Barrington Research cut shares of Dentsply International from an “outperform” rating to a “market perform” rating in a report on Monday, August 8th. Zacks Investment Research cut shares of Dentsply International from a “buy” rating to a “hold” rating in a report on Monday, August 8th. Finally, Jefferies Group reissued a “buy” rating on shares of Dentsply International in a report on Wednesday, August 17th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $66.82.
In related news, SVP Maureen J. Macinnis sold 17,650 shares of the company’s stock in a transaction on Tuesday, August 23rd. The shares were sold at an average price of $60.61, for a total value of $1,069,766.50. Following the completion of the sale, the senior vice president now owns 19,630 shares in the company, valued at approximately $1,189,774.30. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Maureen J. Macinnis sold 45,100 shares of the company’s stock in a transaction on Thursday, August 25th. The shares were sold at an average price of $60.55, for a total transaction of $2,730,805.00. Following the completion of the sale, the senior vice president now owns 36,730 shares of the company’s stock, valued at approximately $2,224,001.50. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.
Dentsply International Company Profile
DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dentsply International Inc. (NASDAQ:XRAY).
Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.